Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
CRITICAL RISK
Score updated Aug 28, 2026

SNOA — Sonoma Pharmaceuticals, Inc. Dilution Risk Tracker

Track SNOA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNOA — Get alerts when the score changes →

As of August 28, 2026, Sonoma Pharmaceuticals, Inc. (SNOA) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. Sonoma Pharmaceuticals, Inc. has a market capitalization of $3.96M, 4.79M shares outstanding. Stored dilution-related fields include shelf registration capacity of $5.00M, ATM program capacity of $3.64M, 3.41M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
40
📊 Float Risk
77
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 47%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 71% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 38%
• Active shelf registration ($5M, 126% of market cap)
• Active ATM program with $4M remaining capacity
🔄 Reverse Split model est. 30%
• 50-day avg $1.70 approaching $1 threshold
🔔 Track SNOA — Get forecast alerts →

Market Data

Market Cap$3.96M
Shares Outstanding4.79M
Float1.72M
Cash$5.34M
Debt$611.0K
Short InterestN/A

Institutional Holdings

2.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SNOA for full holder detail →

Short Interest

Short Interest8.4K
Days to Cover1.0
% of Float0.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-03-31
4 INSIDER TRANSACTION 2026-07-09
4 INSIDER TRANSACTION 2026-07-09
4 INSIDER TRANSACTION 2026-07-09
4 INSIDER TRANSACTION 2026-07-09
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SNOA Dilution Snapshot

Sonoma Pharmaceuticals, Inc. (SNOA) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SNOA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNOA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SNOA
SNOA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.